Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2

N Engl J Med. 1994 Oct 6;331(14):918-21. doi: 10.1056/NEJM199410063311405.
No abstract available

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibody Formation
  • B-Lymphocytes / immunology
  • Common Variable Immunodeficiency / immunology*
  • Common Variable Immunodeficiency / therapy*
  • Female
  • Humans
  • Immunoglobulins / blood
  • Interleukin-2 / biosynthesis
  • Interleukin-2 / therapeutic use*
  • Interleukin-6 / biosynthesis
  • Lymphocyte Activation
  • Middle Aged
  • Recombinant Proteins / therapeutic use
  • Time Factors

Substances

  • Immunoglobulins
  • Interleukin-2
  • Interleukin-6
  • Recombinant Proteins